Microscopic Polyangiitis (MPA): Clinical Trials

2 completed. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Completed 2

Follow Microscopic Polyangiitis (MPA): new trials by email Literature Review of Microscopic Polyangiitis (MPA) trials Research Report on Microscopic Polyangiitis (MPA)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis Rituximab, placebo - Microscopic Polyangiitis (MPA)	Phase 3	Completed	Assistance Publique - Hôpitaux de Paris	8	2020-10-24	2026-05-06
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis Plasma Exchange, No Plasma Exchange, Glucocorticoids [Standard Dose] - Granulomatosis With Polyangiitis (Wegener's) (GPA), Microscopic Polyangiitis (MPA)	Phase 3	Completed	University of Pennsylvania	704	2010-05-01	2020-05-26

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Microscopic Polyangiitis (2)  ·  Granulomatosis with Polyangiitis (1)  ·  Vasculitis (1)

Broader conditions

Autoimmune Diseases (2)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebral Small Vessel Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Immune System Diseases (2)  ·  Nervous System Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Vascular (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Systemic Vasculitis (2)  ·  Vascular Diseases (2)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)

Interventions

Glucocorticoids (1)  ·  Plasma Exchange (1)  ·  Rituximab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  University of Pennsylvania (1)

Countries

France (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Greece (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

David Jayne, MD (1)  ·  Luc Mouthon, MD PhD (1)  ·  Michael Walsh, MD (1)  ·  Peter Merkel, MD, MPH (1)

Results publications

PMID 32053298, PMID 36155131, PMID 38346237

NIH funding

2009 (1), 2018 (1)